常规乳头肌复位联合室间隔心肌切除术治疗梗阻性肥厚型心肌病
本研究描述在20个月内于本机构接受乳头肌复位(PMR)联合室间隔心肌切除术的44例梗阻性肥厚型心肌病(HCM)患者的经验。术后平均静息和应激左心室流出道(LVOT)压差降至正常(分别为12和27 mm Hg,p < 0.0001),无患者出现重度二尖瓣反流(MR),仅3例(6.8%)有中度MR(p < 0.0001),无死亡。结论认为该联合手术安全、高效、可重复,能可靠解除LVOT梗阻并纠正MR,无需二尖瓣修复或置换。
要点
- 44例梗阻性HCM患者接受PMR联合室间隔心肌切除术,术前70%为NYHA III或IV级。
- 术后平均静息和应激LVOT压差分别降至12和27 mm Hg(p < 0.0001)。
- 术后无重度MR,仅3例(6.8%)有中度MR(p < 0.0001),无死亡。
核心结论
- 室间隔心肌切除术联合PMR是安全、高效、可重复的手术,能可靠解除LVOT梗阻并纠正MR,无需二尖瓣修复或置换。
研究设计与样本
- 本研究为单中心前瞻性收集心脏手术数据库资料的病例系列,纳入20个月内于本机构接受PMR联合室间隔心肌切除术的44例梗阻性HCM患者,所有患者术前和术后均接受静息和应激超声心动图检查。
主要发现
- 患者平均年龄54岁(范围18至76岁),术前70%为纽约心脏协会(NYHA)功能III或IV级,平均应激LVOT压差为144 mm Hg,应激下重度MR见于81%。
- 附加手术包括心肌束离断(50%)、腱索离断(43%)和副乳头肌切除(25%)。
- 术后平均静息和应激LVOT压差分别降至12和27 mm Hg(p < 0.0001),无患者有重度MR,仅3例(6.8%)有中度MR(p < 0.0001)。
- 平均住院时间为6天,无死亡。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Septal myectomy has been the mainstay of the surgical treatment of obstructive hypertrophic cardiomyopathy (HCM); however, recently there is growing appreciation for associated mitral valve abnormalities that contribute to left ventricular outflow tract (LVOT) obstruction. In this study, we describe our experience with combined papillary muscle realignment (PMR) and septal myectomy for the treatment of obstructive HCM. METHODS: We identified 44 patients undergoing surgery for obstructive HCM whose anatomy was amenable to combined PMR and septal myectomy at our institution over a 20-month period. All patients underwent resting and stress echocardiography preoperatively and postoperatively. Demographic, clinical, and imaging data were prospectively collected in a cardiac surgery database. RESULTS: Patient age ranged broadly, with mean age of 54 (range, 18 to 76) years. Preoperatively, 70% of patients were New York Heart Association functional class III or IV, the mean stress LVOT gradient was 144 mm Hg, and severe mitral regurgitation (MR) with stress was seen in 81%. Additional procedures included division of myocardial bands (50%) and chordae (43%) and resection of accessory papillary muscles (25%). Following the procedure, mean resting and stress gradients were reduced to normal (12 and 27 mm Hg, respectively; p < 0.0001). No patient had severe MR and only 3 (6.8%) had moderate MR (p < 0.0001). Mean length of stay was 6 days and there were no mortalities. CONCLUSIONS: Septal myectomy combined with PMR is a safe, highly effective, and reproducible procedure that reliably relieves LVOT obstruction and corrects MR without the need for mitral valve repair or replacement.
引用
- Song HK, Turner J, Macfie R, et al. Routine Papillary Muscle Realignment and Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy. Ann Thorac Surg. 2018. PMID: 29753818. doi:10.1016/j.athoracsur.2018.04.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。